Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 27

1.

Impact of body mass index on the five-year outcome of patients having percutaneous coronary interventions with drug-eluting stents.

Sarno G, Räber L, Onuma Y, Garg S, Brugaletta S, van Domburg RT, Pilgrim T, Pfäffli N, Wenaweser P, Windecker S, Serruys P.

Am J Cardiol. 2011 Jul 15;108(2):195-201. doi: 10.1016/j.amjcard.2011.03.023. Epub 2011 Apr 29.

PMID:
21529741
2.

The influence of polyvascular disease on the obesity paradox in vascular surgery patients.

van Kuijk JP, Flu WJ, Galal W, Chonchol M, Goei D, Verhagen HJ, Bax JJ, Poldermans D.

J Vasc Surg. 2011 Feb;53(2):399-406. doi: 10.1016/j.jvs.2010.08.048. Epub 2010 Oct 20.

3.

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Kushner FG, Hand M, Smith SC Jr, King SB 3rd, Anderson JL, Antman EM, Bailey SR, Bates ER, Blankenship JC, Casey DE Jr, Green LA, Hochman JS, Jacobs AK, Krumholz HM, Morrison DA, Ornato JP, Pearle DL, Peterson ED, Sloan MA, Whitlow PL, Williams DO; American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.

Circulation. 2009 Dec 1;120(22):2271-306. doi: 10.1161/CIRCULATIONAHA.109.192663. Epub 2009 Nov 18. No abstract available. Erratum in: Circulation. 2010 Mar 30;121(12):e257. Dosage error in article text.

4.

Obesity paradox in a cohort of 4880 consecutive patients undergoing percutaneous coronary intervention.

Hastie CE, Padmanabhan S, Slack R, Pell AC, Oldroyd KG, Flapan AD, Jennings KP, Irving J, Eteiba H, Dominiczak AF, Pell JP.

Eur Heart J. 2010 Jan;31(2):222-6. doi: 10.1093/eurheartj/ehp317. Epub 2009 Aug 17.

5.

Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.

Lavie CJ, Milani RV, Ventura HO.

J Am Coll Cardiol. 2009 May 26;53(21):1925-32. doi: 10.1016/j.jacc.2008.12.068. Review.

6.

Body mass index, periprocedural bleeding, and outcome following percutaneous coronary intervention (from the British Columbia Cardiac Registry).

Byrne J, Spence MS, Fretz E, Mildenberger R, Chase A, Berry B, Pi D, Janssen C, Klinke P, Hilton D.

Am J Cardiol. 2009 Feb 15;103(4):507-11. doi: 10.1016/j.amjcard.2008.10.027.

PMID:
19195511
7.

The obesity paradox in patients with peripheral arterial disease.

Galal W, van Gestel YR, Hoeks SE, Sin DD, Winkel TA, Bax JJ, Verhagen H, Awara AM, Klein J, van Domburg RT, Poldermans D.

Chest. 2008 Nov;134(5):925-30. doi: 10.1378/chest.08-0418. Epub 2008 Jul 18.

PMID:
18641109
8.

Medical therapies and invasive treatments for coronary artery disease by body mass: the "obesity paradox" in the Get With The Guidelines database.

Steinberg BA, Cannon CP, Hernandez AF, Pan W, Peterson ED, Fonarow GC.

Am J Cardiol. 2007 Nov 1;100(9):1331-5. Epub 2007 Aug 13.

PMID:
17950785
9.

Obesity paradox in patients with hypertension and coronary artery disease.

Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ.

Am J Med. 2007 Oct;120(10):863-70.

PMID:
17904457
10.

Body mass index and mortality in men: evaluating the shape of the association.

Gelber RP, Kurth T, Manson JE, Buring JE, Gaziano JM.

Int J Obes (Lond). 2007 Aug;31(8):1240-7. Epub 2007 Mar 6.

PMID:
17342077
11.

Association of bodyweight with total mortality and with cardiovascular events in coronary artery disease: a systematic review of cohort studies.

Romero-Corral A, Montori VM, Somers VK, Korinek J, Thomas RJ, Allison TG, Mookadam F, Lopez-Jimenez F.

Lancet. 2006 Aug 19;368(9536):666-78. Review.

PMID:
16920472
12.

Commentary: understanding the epidemiology of overweight and obesity--a real global public health concern.

Kim S, Popkin BM.

Int J Epidemiol. 2006 Feb;35(1):60-7; discussion 81-2. Epub 2005 Dec 8. No abstract available.

13.

The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.

Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT.

J Am Coll Cardiol. 2005 Apr 5;45(7):1135-41.

14.

Impact of body mass index on in-hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry).

Minutello RM, Chou ET, Hong MK, Bergman G, Parikh M, Iacovone F, Wong SC.

Am J Cardiol. 2004 May 15;93(10):1229-32.

PMID:
15135694
15.

Unrestricted utilization of sirolimus-eluting stents compared with conventional bare stent implantation in the "real world": the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry.

Lemos PA, Serruys PW, van Domburg RT, Saia F, Arampatzis CA, Hoye A, Degertekin M, Tanabe K, Daemen J, Liu TK, McFadden E, Sianos G, Hofma SH, Smits PC, van der Giessen WJ, de Feyter PJ.

Circulation. 2004 Jan 20;109(2):190-5. Epub 2003 Dec 22.

16.

The relationship between cholesterol and survival in patients with chronic heart failure.

Rauchhaus M, Clark AL, Doehner W, Davos C, Bolger A, Sharma R, Coats AJ, Anker SD.

J Am Coll Cardiol. 2003 Dec 3;42(11):1933-40.

17.

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study).

Fox KM; EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators.

Lancet. 2003 Sep 6;362(9386):782-8.

PMID:
13678872
19.

Association of body mass index with outcome after percutaneous coronary intervention.

Powell BD, Lennon RJ, Lerman A, Bell MR, Berger PB, Higano ST, Holmes DR Jr, Rihal CS.

Am J Cardiol. 2003 Feb 15;91(4):472-6. No abstract available.

PMID:
12586271
20.

Impact of body mass index on outcome after percutaneous coronary intervention (the obesity paradox).

Gurm HS, Brennan DM, Booth J, Tcheng JE, Lincoff AM, Topol EJ.

Am J Cardiol. 2002 Jul 1;90(1):42-5. No abstract available.

PMID:
12088778
Items per page

Supplemental Content

Write to the Help Desk